|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
25,750,000 |
Market
Cap: |
459.38(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.1 - $22.08 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 14.6 |
Insider 6 Months : 14.6 |
Insider 3/6 Months : 29.5 |
|
Guru Rank Number : 140 |
Guru Rank Value : 7.2 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
179,000 |
179,000 |
257,300 |
699,568 |
Total Buy Value |
$1,948,031 |
$1,948,031 |
$2,938,957 |
$7,583,356 |
Total People Bought |
2 |
2 |
3 |
3 |
Total Buy Transactions |
7 |
7 |
13 |
15 |
Total Shares Sold |
0 |
0 |
0 |
40,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$504,800 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kammer Robert J |
Director |
|
2018-09-04 |
4 |
AS |
$3.00 |
$30,000 |
D/D |
(10,000) |
919,827 |
|
- |
|
Kammer Robert J |
Director |
|
2018-08-10 |
4 |
AS |
$3.00 |
$390,000 |
D/D |
(130,000) |
929,827 |
|
- |
|
Saharek John P. |
Chief Commercial Officer |
|
2018-02-01 |
4 |
OE |
$1.83 |
$54,900 |
D/D |
30,000 |
30,000 |
|
- |
|
Boll Andrew |
Chief Financial Officer |
|
2018-02-01 |
4 |
OE |
$1.83 |
$54,900 |
D/D |
30,000 |
84,000 |
|
- |
|
Kammer Robert J |
Director |
|
2017-07-17 |
4 |
AS |
$3.05 |
$30,526 |
D/D |
(10,000) |
1,059,827 |
|
- |
|
Lindstrom Richard L Md |
Director |
|
2017-04-27 |
4 |
OE |
$1.79 |
$179,000 |
I/I |
100,000 |
100,000 |
|
- |
|
Lindstrom Richard L Md |
Director |
|
2016-12-19 |
4 |
B |
$1.79 |
$179,000 |
D/D |
100,000 |
100,000 |
2.39 |
- |
|
Baum Mark L |
Chief Executive Officer |
|
2016-12-19 |
4 |
D |
$1.72 |
$143,979 |
D/D |
(83,709) |
442,126 |
|
- |
|
Baum Mark L |
Chief Executive Officer |
|
2016-12-19 |
4 |
OE |
$1.72 |
$344,000 |
D/D |
200,000 |
525,835 |
|
- |
|
Baum Mark L |
Chief Executive Officer |
|
2016-12-19 |
4 |
B |
$1.79 |
$279,240 |
D/D |
156,000 |
325,835 |
2.81 |
- |
|
Boll Andrew |
Chief Financial Officer |
|
2016-12-19 |
4 |
B |
$1.79 |
$69,810 |
D/D |
39,000 |
54,000 |
2.74 |
- |
|
Kammer Robert J |
Director |
|
2016-11-02 |
4 |
A |
$4.58 |
$435,100 |
D/D |
95,000 |
1,089,827 |
|
- |
|
Opaleye Management Inc. |
10% Owner |
|
2016-03-11 |
4 |
B |
$3.65 |
$164,250 |
I/I |
45,000 |
1,250,000 |
1.5 |
- |
|
Boll Andrew |
Chief Financial Officer |
|
2016-02-01 |
4 |
OE |
$3.68 |
$55,200 |
D/D |
15,000 |
202,500 |
|
- |
|
Principi Anthony |
Director |
|
2015-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,573 |
4,573 |
|
- |
|
Lindstrom Richard L Md |
Director |
|
2015-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,469 |
10,750 |
|
- |
|
Opaleye Management Inc. |
10% Owner |
|
2015-06-30 |
4 |
B |
$7.90 |
$276,500 |
I/I |
35,000 |
1,205,000 |
1.5 |
- |
|
Miloni Donald Paul |
10% Owner |
|
2015-05-19 |
4 |
S |
$8.00 |
$880,198 |
D/D |
(110,000) |
468,576 |
|
- |
|
Opaleye Management Inc. |
10% Owner |
|
2015-05-19 |
4 |
B |
$8.00 |
$22,408 |
I/I |
2,801 |
1,170,000 |
1.5 |
- |
|
Opaleye Management Inc. |
10% Owner |
|
2015-05-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,167,199 |
|
- |
|
Miloni Donald Paul |
10% Owner |
|
2015-05-18 |
4 |
S |
$8.00 |
$2,400,000 |
D/D |
(300,000) |
578,576 |
|
- |
|
Nelson William H. |
Director |
|
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,281 |
12,904 |
|
- |
|
Lindstrom Richard L Md |
Director |
|
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,281 |
6,281 |
|
- |
|
Kammer Robert J |
Director |
|
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,281 |
994,827 |
|
- |
|
Austin Stephen G |
Director |
|
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,281 |
19,769 |
|
- |
|
181 Records found
|
|
Page 5 of 8 |
|
|